Global private equity and venture capital news and research

Private equity-backed Omega Pharma clinches €470m GSK portfolio $

16 Mar 2012

Omega Pharma , the Belgian pharmaceutical group backed by Dutch buy-out firm Waterland, has clinched a deal to buy a €470m portfolio of over-the counter drugs owned by British pharma giant GlaxoSmithKline.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016